Stocktoria

BiomX Inc. PHGE

NYSE American · XASE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-12-18

BiomX Inc. (PHGE) earns a Piotroski F-score of 1/9 (weak financial health). It does not currently pay a dividend.

Chart by TradingView
1/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
$0.34 as of 2026-06-01 · -96% 1y
$0.34$10.2652-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

How it ranks in Manufacturing · percentile among 1829 companies

Piotroski Fstronger than 1%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 1/9 tests passed

Detailed pages

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
PHGEBiomX Inc.1/9
AMGNAMGEN INC6/90.1425.1+10%
GILDGILEAD SCIENCES, INC.7/93.2818.7+2.4%
BIIBBIOGEN INC.4/924.7+2.2%
NBIXNEUROCRINE BIOSCIENCES INC5/96.2135.4+21.4%
EXELEXELIXIS, INC.6/97.6917.6+7%
QGENQIAGEN N.V.7/95.0619.1+5.7%

All Manufacturing companies →

FAQ

Is PHGE financially healthy?

BiomX Inc.'s Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak).

Does PHGE pay a dividend?

No, BiomX Inc. does not currently pay a dividend.

Source: SEC EDGAR filings · CIK 0001739174 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.